The Centers for Disease Control and Prevention has updated respiratory syncytial virus vaccination recommendations for adults 60 and older. Adults aged 60-74 at increased risk for RSV and all aged 75 and older are recommended a single dose of the GSK, Pfizer or Moderna vaccine. Individuals who previously received a dosage should not seek another. 

Related News Articles

Headline
The Department of Agriculture March 20 announced it will fund up to $100 million for projects exploring prevention, therapeutics, research and potential…
Headline
There are 378 confirmed cases of measles in 17 states across the country, according to the latest data from the Centers for Disease Control and Prevention. The…
Headline
There have been 301 confirmed cases of measles across the U.S. so far this year, surpassing the 2024 total of 285, according to the latest data from the…
Headline
The Centers for Disease Control and Prevention today released a health advisory on the measles outbreak in Texas and New Mexico. As of today, Texas has…
Headline
The Centers for Disease Control and Prevention March 4 announced it sent agency experts to Texas to assist local officials in responding to the state’s measles…
Headline
A school-aged child in Texas is the first reported individual to die from measles amid an outbreak in the South Plains and Panhandle regions of the state, the…